Stephen JD - Sight Sciences Secretary
SGHT Stock | USD 5.67 0.33 6.18% |
Executive
Stephen JD is Secretary of Sight Sciences
Address | 4040 Campbell Avenue, Menlo Park, CA, United States, 94025 |
Phone | 877 266 1144 |
Web | https://www.sightsciences.com |
Sight Sciences Management Efficiency
The company has return on total asset (ROA) of (0.1932) % which means that it has lost $0.1932 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4284) %, meaning that it created substantial loss on money invested by shareholders. Sight Sciences' management efficiency ratios could be used to measure how well Sight Sciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.35 in 2024. Return On Capital Employed is likely to drop to -0.39 in 2024. At this time, Sight Sciences' Non Current Liabilities Total is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 4.4 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 11.6 M in 2024.Similar Executives
Found 11 records | EXECUTIVE Age | ||
Emily Faucette | Talis Biomedical Corp | N/A | |
Vadim Sapiro | OpGen Inc | 53 | |
Rebecca Markovich | Talis Biomedical Corp | 50 | |
Kimberly Bambach | Tivic Health Systems | 52 | |
Robert Bowdring | INVO Bioscience | 66 | |
Gillian Green | Talis Biomedical Corp | N/A | |
Jill Green | Talis Biomedical Corp | N/A | |
Susan RN | NeuroMetrix | N/A | |
Oliver Schacht | OpGen Inc | 53 | |
Theo deVos | OpGen Inc | N/A | |
Deina Walsh | Bone Biologics Corp | 60 |
Management Performance
Return On Equity | -0.43 | ||||
Return On Asset | -0.19 |
Sight Sciences Leadership Team
Elected by the shareholders, the Sight Sciences' board of directors comprises two types of representatives: Sight Sciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sight. The board's role is to monitor Sight Sciences' management team and ensure that shareholders' interests are well served. Sight Sciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sight Sciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
MBA BS, VP Operations | ||
Stacie Rodgers, VP HR | ||
John Liu, VP Access | ||
Stephen JD, Secretary | ||
Sam Park, Chief Officer | ||
John Ordway, VP Operations | ||
Matthew Link, Chief Officer | ||
Paul Badawi, President, CoFounder | ||
Steve Tamayo, VP Officer | ||
Tom Huang, Head Development | ||
Alison Bauerlein, CFO Treasurer | ||
Reay Brown, Chief Officer | ||
David MD, CTO Founder | ||
Jesse Selnick, Chief Officer | ||
Jeremy Hayden, Chief Officer |
Sight Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sight Sciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.43 | ||||
Return On Asset | -0.19 | ||||
Profit Margin | (0.67) % | ||||
Operating Margin | (0.76) % | ||||
Current Valuation | 173.42 M | ||||
Shares Outstanding | 49.76 M | ||||
Shares Owned By Insiders | 20.64 % | ||||
Shares Owned By Institutions | 50.92 % | ||||
Number Of Shares Shorted | 1.38 M | ||||
Price To Book | 2.12 X |
Pair Trading with Sight Sciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sight Sciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sight Sciences will appreciate offsetting losses from the drop in the long position's value.Moving against Sight Stock
0.9 | BIMI | Bimi International | PairCorr |
0.81 | CTKB | Cytek Biosciences | PairCorr |
0.79 | SSY | SunLink Health Systems | PairCorr |
0.7 | NVST | Envista Holdings Corp | PairCorr |
0.69 | TFX | Teleflex Incorporated | PairCorr |
The ability to find closely correlated positions to Sight Sciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sight Sciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sight Sciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sight Sciences to buy it.
The correlation of Sight Sciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sight Sciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sight Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sight Sciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sight Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For more information on how to buy Sight Stock please use our How to Invest in Sight Sciences guide.Note that the Sight Sciences information on this page should be used as a complementary analysis to other Sight Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for Sight Stock analysis
When running Sight Sciences' price analysis, check to measure Sight Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sight Sciences is operating at the current time. Most of Sight Sciences' value examination focuses on studying past and present price action to predict the probability of Sight Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sight Sciences' price. Additionally, you may evaluate how the addition of Sight Sciences to your portfolios can decrease your overall portfolio volatility.
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
Is Sight Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sight Sciences. If investors know Sight will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sight Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.12) | Revenue Per Share 1.667 | Quarterly Revenue Growth 0.023 | Return On Assets (0.19) | Return On Equity (0.43) |
The market value of Sight Sciences is measured differently than its book value, which is the value of Sight that is recorded on the company's balance sheet. Investors also form their own opinion of Sight Sciences' value that differs from its market value or its book value, called intrinsic value, which is Sight Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sight Sciences' market value can be influenced by many factors that don't directly affect Sight Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sight Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sight Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sight Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.